Ftse Mib
37.675,40
-1,44%
DAX
22.328,77
-1,23%
S&P 500
5.607,57
-0,12%
NASDAQ
17.561,98
0,54%
Bitcoin
83.406,19
6,29%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Lantheus Holdings Inc (LNTH) Lantheus Holdings Inc (LNTH) Notizie

Lantheus Holdings Inc

LNTH
105,475
-4,54 (-4,12%)
Ultimo aggiornamento: 20:17:53
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/3/202523:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202523:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202523:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/3/202523:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202523:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202516:17EDGAR2Form 144 - Report of proposed sale of securities
28/2/202521:31EDGAR2Form 144 - Report of proposed sale of securities
26/2/202513:56EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
26/2/202513:42EDGAR2Form 8-K - Current report
26/2/202513:00GLOBELantheus Reports Fourth Quarter and Full Year 2024 Financial..
21/2/202514:30GLOBELantheus to Present at Upcoming Investor Conferences
12/2/202514:00GLOBELantheus to Host Fourth Quarter and Full Year 2024 Earnings..
11/2/202522:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/2/202500:34EDGAR2Form 3 - Initial statement of beneficial ownership of..
05/2/202514:30GLOBELantheus Announces Presentations Featuring PYLARIFY..
30/1/202514:44EDGAR2Form 8-K - Current report
30/1/202514:30GLOBELantheus Appoints Phuong Khanh (P.K.) Morrow, M.D., as New..
28/1/202512:30PRNUSLantheus to Acquire Evergreen Theragnostics for Upfront..
28/1/202512:23EDGAR2Form 8-K - Current report
28/1/202512:00GLOBELantheus to Acquire Evergreen Theragnostics for Upfront..
13/1/202506:05GLOBELantheus to Acquire Life Molecular Imaging for an Upfront..
23/12/202422:32EDGAR2Form 8-K - Current report
19/12/202422:30EDGAR2Form 8-K - Current report
20/11/202412:07EDGAR2Form 8-K - Current report
20/11/202407:00GLOBELantheus Announces Share Repurchase Program
19/11/202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/11/202423:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/11/202417:59EDGAR2Form 144 - Report of proposed sale of securities
14/11/202416:07EDGAR2Form 144 - Report of proposed sale of securities
13/11/202414:30GLOBELantheus to Present at the Jefferies London Healthcare..
12/11/202423:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/11/202413:39GLOBELantheus Continues to Commend CMS’ CY25 Rule to Enhance..
08/11/202422:38EDGAR2Form 144 - Report of proposed sale of securities
06/11/202413:42EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/11/202413:37EDGAR2Form 8-K - Current report
06/11/202413:00GLOBELantheus Reports Third Quarter 2024 Financial Results
04/11/202413:30GLOBELantheus Applauds CMS’ CY25 Rule to Enhance Payment for..
23/10/202414:30GLOBELantheus to Host Third Quarter 2024 Earnings Conference Call..
15/10/202414:28EDGAR2Form 144 - Report of proposed sale of securities
25/9/202422:44EDGAR2Form 8-K - Current report
15/9/202414:45GLOBELantheus Presents Results from the Primary Analysis of Phase..
13/9/202419:29EDGAR2Form 144 - Report of proposed sale of securities
05/9/202414:38EDGAR2Form 8-K - Current report
05/9/202414:30GLOBELantheus Appoints Julie Eastland as New Board Member
03/9/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202414:30GLOBELantheus to Present at the Morgan Stanley 22nd Annual Global..
Apertura: 109,81 Min: 104,59 Max: 111,29
Chiusura: 110,01

La tua Cronologia

NASDAQ
LNTH
Lantheus
ASX
BSX
Blackstone Minerals
NASDAQ
VEEA
Veea
LSE
0RV9
Biom Up
BIT
CIT
UBS LUX Fnd Solut Solact...
NYSE
WMS
Advanced Drainage Systems
NYSE
BTA
BlackRock Long Term Muni...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network

Rimuovi gli annunci

Iscriviti per un'esperienza senza pubblicità

Nessuna pubblicità

Prova adesso

Conserva gli annunci